Coronavirus (COVID-19)
KFF COVID-19 Vaccine Monitor: Enthusiasm Rising Across Racial, Ethnic and Partisan Groups
-
March 1, 2021
Vaccine Confidence Isn’t The Main Obstacle To Reaching Herd Immunity
-
February 24, 2021
Is the End of the Long-Term Care Crisis Within Sight? New COVID-19 Cases and Deaths in Long-Term Care Facilities Are Dropping
-
February 22, 2021
Growing Gaps in COVID-19 Vaccinations among Hispanic People
Latest from Kaiser Health News
-
Readers and Tweeters Dispense Timely Advice for Difficult Times
-
Beijing’s SARS Lockdown Taught My Children Resilience. Your Covid Kids Will Likely Be Fine.
-
Black Churches Fill a Unique Role in Combating Vaccine Fears
-
Connecticut Is Doling Out Vaccines Based Strictly on Age. It’s Simpler, but Is it Fair?
COVID-19 Vaccine Monitor Dashboard
Latest PollingState Data and Policy Actions to Address Coronavirus
There have been over 3 million cases and 131,000 deaths due to COVID-19 in the U.S. Every state and Washington D.C. have eased or lifted at least one social distancing requirement — including 39 states that have eased or lifted stay-at-home orders.
COVID-19 Coronavirus Tracker
This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths. There have been over 11.8 million confirmed cases and 544,000 confirmed deaths worldwide.
Medicaid Emergency Authority Tracker: Approved State Actions to Address COVID-19
39 states are now addressing the coronavirus emergency with Medicaid/CHIP Disaster Relief State Plan Amendments (SPAs). This tracker also includes details on Section 1135 waivers and 1915 (c) Waiver Appendix K strategies and is regularly updated.
COVID-19 and Related State Data
Use this tool to create custom reports of COVID-19 and related state data. Group COVID-19 cases and deaths with indicators like total hospital beds, health insurance coverage and unemployment claims.
-
What Does a Multi-Dose Series Mean for the COVID-19 Vaccination Effort?
This issue brief examines key issues related to multi-dose vaccination series generally as well as issues specific to COVID-19.
-
COVAX and the United States
This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX’s organization, conditions for country participation, activities, and financing structure. Additionally, it looks at the history and remaining key issues of U.S. engagement with COVAX.
-
KFF COVID-19 Vaccine Monitor: December 2020
This initial survey for the KFF COVID-19 Vaccine Monitor tracks the public’s attitudes and experiences with COVID-19 vaccinations, with a focus on sub-groups of Americans. It explores confidence in vaccines, assesses trust in messengers, and highlights key challenges for vaccination efforts.
-
Addressing Racial Equity in Vaccine Distribution
This brief provides an overview of barriers to vaccination that disproportionately affect people of color and discusses how current national recommendations and state vaccine allocation plans address racial equity.
COVID-19 Risks and Impacts Among Health Care Workers by Race/Ethnicity
This analysis provides insight into COVID-19 risks and impacts among health care workers and how they vary by race and ethnicity.
COVID-19 Racial Disparities in Testing, Infection, Hospitalization, and Death: Analysis of Epic Patient Data
This analysis builds on a continually growing body of research on racial disparities in COVID-19 by examining testing, infection, hospitalization, and death by race and ethnicity among patients in the Epic health record system.
Low-Income and Communities of Color at Higher Risk of Serious Illness if Infected with Coronavirus
This date note examines the share of non-elderly adults at higher risk of serious illness if infected with coronavirus by race/ethnicity and household income in 2018.
At-Home SARS-CoV-2 Testing: What Are the Options?
This interactive table includes vendors selling at-home SARS-CoV-2 diagnostic tests that have received emergency use authorization (EUA) from the Food and Drug Administration (FDA).
Five Things to Know about the Cost of COVID-19 Testing and Treatment
This brief answer key questions on affordability of COVID-19 testing and treatment for people who are uninsured and those insured through private coverage, Medicare, and Medicaid.
FAQs on Medicare Coverage and Costs Related to COVID-19 Testing and Treatment
These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries.
Key Questions About the New Medicaid Eligibility Pathway for Uninsured Coronavirus Testing
This issue brief answers key questions about how the new eligibility pathway is being implemented, drawing on frequently asked questions issued by the Centers for Medicare and Medicaid Services.